Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373

1.

Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.

Drescher SM, von Wyl V, Yang WL, Böni J, Yerly S, Shah C, Aubert V, Klimkait T, Taffé P, Furrer H, Battegay M, Ambrosioni J, Cavassini M, Bernasconi E, Vernazza PL, Ledergerber B, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

Clin Infect Dis. 2014 Jan;58(2):285-94. doi: 10.1093/cid/cit694. Epub 2013 Oct 21.

PMID:
24145874
2.

Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.

Holguín Á, Yebra G, Martín L, de Pineda AT, Ruiz LE, Quezada AY, Nieto AI, Escobar G.

Clin Microbiol Infect. 2013 Dec;19(12):E523-32. doi: 10.1111/1469-0691.12264. Epub 2013 Jun 19.

3.

Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.

Zhao B, Han X, Xu J, Hu Q, Chu Z, Zhang J, Lu L, Wang Z, Fu J, Chen X, Yan H, Zhuang M, Wang L, Sun A, Zhang CM, Shang H.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):250-5. doi: 10.1097/QAI.0000000000000467.

PMID:
25469530
4.

Prevalence and patterns of HIV transmitted drug resistance in Guatemala.

Avila-Ríos S, Mejía-Villatoro CR, García-Morales C, Soto-Nava M, Escobar I, Mendizabal R, Girón A, García L, Reyes-Terán G.

Rev Panam Salud Publica. 2011 Dec;30(6):641-8.

5.

High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.

Franzetti M, Lai A, Simonetti FR, Bozzi G, De Luca A, Micheli V, Meraviglia P, Corsi P, Bagnarelli P, Almi P, Zoncada A, Balotta C.

J Antimicrob Chemother. 2012 May;67(5):1250-3. doi: 10.1093/jac/dks013. Epub 2012 Feb 1.

PMID:
22302564
6.

Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.

Yang WL, Kouyos R, Scherrer AU, Böni J, Shah C, Yerly S, Klimkait T, Aubert V, Furrer H, Battegay M, Cavassini M, Bernasconi E, Vernazza P, Held L, Ledergerber B, Günthard HF; Swiss HIV Cohort Study.

J Infect Dis. 2015 Jul 1;212(1):28-38. doi: 10.1093/infdis/jiv012. Epub 2015 Jan 9.

7.

Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.

Onywera H, Maman D, Inzaule S, Auma E, Were K, Fredrick H, Owiti P, Opollo V, Etard JF, Mukui I, Kim AA, Zeh C.

PLoS One. 2017 Feb 8;12(2):e0171124. doi: 10.1371/journal.pone.0171124. eCollection 2017.

8.

Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.

Skoura L, Metallidis S, Buckton AJ, Mbisa JL, Pilalas D, Papadimitriou E, Papoutsi A, Haidich AB, Chrysanthidis T, Tsachouridou O, Antoniadou ZA, Kollaras P, Nikolaidis P, Malisiovas N.

J Antimicrob Chemother. 2011 Dec;66(12):2831-7. doi: 10.1093/jac/dkr386. Epub 2011 Sep 19.

PMID:
21933785
9.

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.

Karlsson A, Björkman P, Bratt G, Ekvall H, Gisslén M, Sönnerborg A, Mild M, Albert J.

PLoS One. 2012;7(3):e33484. doi: 10.1371/journal.pone.0033484. Epub 2012 Mar 20.

10.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children.

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

PMID:
21810838
11.

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.

Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, Takou D, Nanfack A, Dori L, Torimiro J, Sarmati L, Andreoni M, Perno CF, Colizzi V, Cappelli G.

J Med Virol. 2012 May;84(5):721-7. doi: 10.1002/jmv.23244.

PMID:
22431019
12.

HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.

Cardoso LP, Queiroz BB, Stefani MM.

J Clin Virol. 2009 Oct;46(2):134-9. doi: 10.1016/j.jcv.2009.07.009. Epub 2009 Aug 13.

PMID:
19682948
13.

Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.

Kleyn TJ, Liedtke MD, Harrison DL, Lockhart SM, Salvaggio MR, Ripley TL, Rathbun RC.

Ann Pharmacother. 2014 Apr;48(4):470-5. doi: 10.1177/1060028013519246. Epub 2014 Jan 28.

PMID:
24473489
14.

Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.

Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.

Infect Genet Evol. 2009 Jul;9(4):646-52. doi: 10.1016/j.meegid.2009.04.002. Epub 2009 Apr 15.

PMID:
19460333
15.

National prevalence and trends of HIV transmitted drug resistance in Mexico.

Avila-Ríos S, García-Morales C, Garrido-Rodríguez D, Ormsby CE, Hernández-Juan R, Andrade-Villanueva J, González-Hernández LA, Torres-Escobar I, Navarro-Álvarez S, Reyes-Terán G; Mexican HIV Molecular Epidemiology Project Group.

PLoS One. 2011;6(11):e27812. doi: 10.1371/journal.pone.0027812. Epub 2011 Nov 15. Erratum in: PLoS One. 2012;7(7): doi/10.1371/annotation/3797af3f-0573-41bf-8d50-05309fd3d187.

16.

Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV.

Kouyos RD, Rauch A, Böni J, Yerly S, Shah C, Aubert V, Klimkait T, Kovari H, Calmy A, Cavassini M, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF; Swiss HIV Cohort Study (SHCS).

Int J Epidemiol. 2014 Jun;43(3):887-96. doi: 10.1093/ije/dyt276. Epub 2014 Jan 22.

PMID:
24453237
17.

Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.

Panichsillapakit T, Smith DM, Wertheim JO, Richman DD, Little SJ, Mehta SR.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):228-36. doi: 10.1097/QAI.0000000000000831.

18.

Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.

Tanuma J, Quang VM, Hachiya A, Joya A, Watanabe K, Gatanaga H, Van Vinh Chau N, Chinh NT, Oka S.

J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):358-64. doi: 10.1097/QAI.0000000000000196.

PMID:
24815852
19.

The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.

Grgic I, Lepej SZ, Lunar MM, Poljak M, Vince A, Vrakela IB, Planinic A, Seme K, Begovac J.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):329-36. doi: 10.1089/AID.2012.0191. Epub 2012 Oct 4.

20.

Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria.

Nazziwa J, Njai HF, Ndembi N, Birungi J, Lyagoba F, Gershim A, Nakiyingi-Miiro J, Nielsen L, Mpendo J, Nanvubya A, Debont J, Grosskurth H, Kamali A, Seeley J, Kaleebu P; Chivtum Study Team.

AIDS Res Hum Retroviruses. 2013 May;29(5):788-95. doi: 10.1089/AID.2012.0123.

Supplemental Content

Support Center